{"cursor":"10071","size":15,"audio":[],"currentlang":"en","article":"{{Infobox company\n| name = Actelion Pharmaceuticals Ltd. logo = caption = Actelion logo image =\n| type = public company foundation = 1997 founder = Jean-Paul Clozel, Martine\n| Clozel, Walter Fischli, AndrÃ© J. MÃ¼ller and Thomas Widmann board = Robert\n| Cawthorn, President of the Board [will step back in 2012] location_city =\n| Allschwil, Basel country location_country = Switzerland location =\n| Gewerbestrasse 16 key_people = Jean-Paul Clozel, Chief Executive Office\n| Guy Braunstein, Global Clinical Development  Otto Schwarz, Chief\n| Operating Officer Nicholas Franco, Chief Business Officer Andrew\n| Oakley,Chief Financial Officer| area_served = Research and Development of\n| medicines for unmet medical need industry = Pharmaceuticals/Biotech products =\n| Tracleer, Ventavis, Zavesca, Veletri revenue = 1,929 mio CHF |title=Annual\n| Report  operating_income = 457.3 mio CHF\n| |title=Annual Report  net_income = 390.6 mio CHF\n| |title=Annual Report  num_employees = 2467 (January\n| 2011) homepage = [http://www.actelion.com www.actelion.com]\n}}\n\n'Actelion' was founded in December 1996 and has its headquarters in Allschwil\nnear Basel (Switzerland). Its CEO and co-founder is\ncardiologist Jean-Paul Clozel. Actelion scientists were among the\nfirst to work in the field of endothelian receptor antagonists. The\ncompany name might be a reminder for its first product, an endothelian receptor\nantagonist and the verb \"action\", \"act upon\". Actelion was initially financed\nwith venture capital provided through a syndicate including among others\nSofinnova and HealthCap.\n\nActelion is specialized in orphan diseases. Often, R&D investments in\nsuch diseases are low because companies see no ROI. Obviously, this is a serious\nproblem for patients affected by a rare disease. Orphan diseases\noften affect very vulnerable patient groups such as children; Actelion keeps\ninvesting in such areas:\n\nMore information on rare diseases: see this year's (2011) worldwide \"Rare\nDisease Day\":\n\nActelion has 29 operative affiliates around the world, including the United\nStates, Canada, Brazil, Australia, Japan, Switzerland and a number of EU\ncountries. The Swiss affiliate is located in Baden, the German affiliate in\nFreiburg, the Austrian one in Vienna, the French one in Paris and the UK\naffiliate is located in London\n\nIn 2006, the company established the Actelion Endothelin Research Award\nprogramme which supports selected clinical research projects.\n","linknr":199,"url":"Actelion","recorded":1376425785,"links":["/w/index.php?title=Actelion&action=edit","/w/index.php?title=Actelion&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Actelion","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/File:Actelion.jpg","//upload.wikimedia.org/wikipedia/en/thumb/3/38/Actelion.jpg/180px-Actelion.jpg","/wiki/Types_of_business_entity","/wiki/Earnings_before_interest_and_taxes","/wiki/Net_income","http://www.actelion.com","#cite_note-FT_1-1","/wiki/Chief_Executive_Officer","/wiki/Cardiologist","#cite_note-2","#cite_note-3","/wiki/Venture_capital","/wiki/Sofinnova","/wiki/HealthCap","#cite_note-4","#cite_note-5","#cite_note-6","#cite_note-7","/wiki/Freiburg","/wiki/Vienna","/wiki/Paris","/wiki/London","#cite_note-8","#Medicines","#Key_figures","#Current_News","#Awards","#References","#External_links","/w/index.php?title=Actelion&action=edit&section=1","/w/index.php?title=Actelion&veaction=edit&section=1","/wiki/Orphan_disease","/wiki/Bosentan","/wiki/Pulmonary_arterial_hypertension","/wiki/Endothelin_receptor_antagonist","/wiki/Endothelin_receptor_antagonist","#cite_note-9","/wiki/Miglustat","/wiki/Gaucher_disease","#cite_note-10","/wiki/Iloprost","/wiki/NYHA","#cite_note-11","/wiki/Epoprostenol","/wiki/Primary_pulmonary_hypertension","/wiki/Pulmonary_hypertension","/wiki/Scleroderma","#cite_note-12","/w/index.php?title=Actelion&action=edit&section=2","/w/index.php?title=Actelion&veaction=edit&section=2","#cite_note-13","/wiki/Swiss_Exchange","/wiki/Swiss_Leader_Index","/wiki/Swiss_Market_Index","#cite_note-FT_1-1","#cite_note-14","#cite_note-15","#cite_note-16","/w/index.php?title=Actelion&action=edit&section=3","/w/index.php?title=Actelion&veaction=edit&section=3","#cite_note-17","#cite_note-18","#cite_note-19","#cite_note-20","/w/index.php?title=Actelion&action=edit&section=4","/w/index.php?title=Actelion&veaction=edit&section=4","#cite_note-21","#cite_note-22","#cite_note-23","http://www.twitter.com/actelion_com","https://www.facebook.com/actelion","http://www.youtube.com/user/DiscoverActelion","/w/index.php?title=Actelion&action=edit&section=5","/w/index.php?title=Actelion&veaction=edit&section=5","#cite_ref-FT_1_1-0","#cite_ref-FT_1_1-1","http://markets.ft.com/tearsheets/performance.asp?s=ch:ATLN","#cite_ref-2","http://www.nature.com/nbt/journal/v25/n2/full/nbt0207-155.html","#cite_ref-3","http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=ATLN:VX","#cite_ref-4","http://www.medterms.com/script/main/art.asp?articlekey=11418","#cite_ref-5","http://www.earth.columbia.edu/cgsd/documents/grabowski.ppt","#cite_ref-6","http://www.bionity.com/en/news/102968/tracleer-bosentan-receives-eu-approval-for-pediatric-formulation.html","#cite_ref-7","http://www.rarediseaseday.org/","#cite_ref-8","http://www.pah-info.com/Affiliates","#cite_ref-9","http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000401/human_med_001100.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d125","#cite_ref-10","http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000435/human_med_001171.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d125","#cite_ref-11","http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000474/human_med_001133.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d125","#cite_ref-12","http://www.news-medical.net/news/20100826/FDA-approves-brand-name-VELETRI-for-Actelions-epoprostenol-for-injection-therapy.aspx","#cite_ref-13","http://www.actelion.com/en/our-company/actelion-worldwide/index.page?","#cite_ref-14","http://www.six-swiss-exchange.com/shares/security_info_en.html?id=CH0010532478CHF1","#cite_ref-15","http://www.ubs.com/1/e/index/bcqv/quotes.html?m%28bcvProfile%29=BCQV_CH&m%28lang%29=en&m%28searchBySymbol%29=GO&m%28searchInput%29=actelion","#cite_ref-16","http://www.thepharmaletter.com/file/89778/switzerlands-actelion-going-public-in-one-of-europes-biggest-biotech-ipos.html","#cite_ref-17","http://www.reuters.com/article/2011/03/07/actelion-idUSLDE7261V820110307","#cite_ref-18","http://www.cnbc.com/id/41969603","#cite_ref-19","http://www.reuters.com/article/2011/05/05/us-actelion-idUSTRE7442HW20110505","#cite_ref-20","http://tsmassociates.com/home-news-view-biopharmaceutical-marketing.php?id=37108&utm_medium=twitter&utm_source=TSM+Associates+-+John+D+Waddell,+RPh","#cite_ref-21","http://www.rencontre-innovation.com/?page_id=7","#cite_ref-22","http://www.rencontre-innovation.com/?page_id=139","#cite_ref-23","http://www.sitemorse.ch/pub/uploads/editor/files/SiteMonitor201101Online.pdf","/w/index.php?title=Actelion&action=edit&section=6","/w/index.php?title=Actelion&veaction=edit&section=6","http://www.actelion.com","http://www.endothelin.org/Rainbow/","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Actelion&oldid=558733951","/wiki/Help:Category","/wiki/Category:Pharmaceutical_companies_of_Switzerland","/w/index.php?title=Special:UserLogin&returnto=Actelion&type=signup","/w/index.php?title=Special:UserLogin&returnto=Actelion","/wiki/Actelion","/wiki/Talk:Actelion","#","/wiki/Actelion","/w/index.php?title=Actelion&action=edit","/w/index.php?title=Actelion&veaction=edit","/w/index.php?title=Actelion&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Actelion","/wiki/Special:RecentChangesLinked/Actelion","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Actelion&oldid=558733951","/w/index.php?title=Actelion&action=info","//www.wikidata.org/wiki/Q343217","/w/index.php?title=Special:Cite&page=Actelion&id=558733951","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Actelion","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Actelion&oldid=558733951&writer=rl","/w/index.php?title=Actelion&printable=yes","//de.wikipedia.org/wiki/Actelion","//fa.wikipedia.org/wiki/%D8%A7%DA%A9%D8%AA%D9%84%DB%8C%D9%88%D9%86","//fr.wikipedia.org/wiki/Actelion","#","//www.wikidata.org/wiki/Q343217#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Actelion","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://www.sitemorse.ch/pub/uploads/editor/files/SiteMonitor201101Online.pdf"],"categories":["Pharmaceutical companies of Switzerland"],"headings":["Medicines","Key figures","Current News","Awards","References","External links"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/3/38/Actelion.jpg/180px-Actelion.jpg","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Chief_Executive_Officer","Cardiologist","Venture_capital","Sofinnova","HealthCap","Freiburg","Vienna","Paris","London","Orphan_disease","Bosentan","Pulmonary_arterial_hypertension","Endothelin_receptor_antagonist","Endothelin_receptor_antagonist","Miglustat","Gaucher_disease","Iloprost","NYHA","Epoprostenol","Primary_pulmonary_hypertension","Pulmonary_hypertension","Scleroderma","Swiss_Exchange","Swiss_Leader_Index","Swiss_Market_Index"]}